Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateOhioIntroduced
HB 1004: Allow pharmacist to dispense nicotine replacement, contraceptives
Adam Bird
HB 1004 status: Introduced (updated Sep 8, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
Not enough information
Score:Not enough information
Risk:Low Risk
Impact:Moderate Impact 55/100
Constitutionality95%
Bipartisan50%
Public opinion75%
Bill summary
To amend sections 4723.4812 and 4729.284; to enact section 4729.286; and to repeal section 4731.90 of the Revised Code to revise the law governing pharmacist dispensing of nicotine replacement therapy and to authorize pharmacists to dispense oral contraceptive therapy pursuant to protocols developed by the State Board of Pharmacy.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
65%
Benefits
- Increases service revenue for community pharmacies
- Broadens the clinical scope of pharmacy operations
- Reduces administrative redundancy for routine prescriptions
Risks
- Increased compliance and training costs for staff
- Potential adjustments to pharmacy professional liability insurance
- Complexity in managing insurance billing for clinical consultations
Society
Positive outlook
70%
Benefits
- Improves community access to reproductive healthcare
- Facilitates easier entry into smoking cessation programs
- Reduces travel barriers for patients in rural regions
Risks
- Risk of regional disparities in pharmacist availability
- Potential variations in protocol consistency across pharmacy locations
- Limited private space for medical screening in some retail settings
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Not enough information
Not enough information to score this sector.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Positive outlook
75%
Benefits
- Supports higher smoking cessation success rates
- Directly reduces barriers to contraception
- Expands clinical pathways for preventative health interventions
Risks
- Possible omission of underlying chronic condition screening
- Limited long-term follow-up compared to traditional clinical settings
- Risk of unidentified medication interactions by non-prescribing providers
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Implementation success depends heavily on the specific safety protocols drafted by the Board of Pharmacy
Analysis scope
Source provided is a summary abstract only; lacks granular legal text
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.